Articles From: UPDATE: 3 health resolutions you can actually keep in 2015 to Verastem Receives Orphan Medicinal Product Designation from the European Commission for VS-5584 in Mesothelioma


2015/1/20
By Elizabeth O'Brien, MarketWatch They say the best exercise program is any one that you can stick with.
Sign-up for UPDATE: 3 health resolutions you can actually keep in 2015 investment picks
2015/1/20
By Quentin Fottrell, MarketWatch What's your poison?
Sign-up for UPDATE: 5 people getting rich off your New Year's resolutions investment picks
2015/1/20
By Paul Brandus, MarketWatch The State of the Union is like the Super Bowl.
Sign-up for UPDATE: A State of the Union scorecard shows Obama can live without Congress investment picks
2015/1/20
Barnes & Noble Inc. (BKS) said on Tuesday that Mitchell Klipper, a 28-year company veteran and head of its retail group, will retire at the end of the current fiscal year, but said he'll remain with the bookstore operator in the role of special adviser on real estate and other matters.
Sign-up for UPDATE: Barnes & Noble says retail group chief to retire investment picks
2015/1/20
Delta Air Lines Inc. shares (DAL) climbed 4.7% in premarket trade Tuesday, after the company reported better-than-expected fourth-quarter adjusted earnings.
Sign-up for UPDATE: Delta Air shares surge 4.7% in premarket trade as earnings beat estimates investment picks
2015/1/20
By Victor Reklaitis, MarketWatch Netflix, IBM, set to grab earnings spotlight NEW YORK (MarketWatch) -- Here are stocks likely to make notable moves Tuesday: Gainers Delta Air Lines Inc. (DAL) reported better-than-expected fourth-quarter adjusted results, with revenue of $8.24 billion, up 4.6%. The airline posted $1.4 billion special-item charge related to hedging fuel costs.
Sign-up for UPDATE: Delta, Smith & Wesson jump; Morgan Stanley disappoints investment picks
2015/1/20
By Wallace Witkowski and Victor Reklaitis, MarketWatch Netflix, IBM next to grab earnings spotlight SAN FRANCISCO (MarketWatch) -- Here are stocks making notable moves Tuesday: Gainers Delta Air Lines Inc. (DAL) reported better-than-expected fourth-quarter adjusted results, with revenue of $8.24 billion, up 4.6%. The airline posted a $1.4 billion special-item charge related to hedging fuel costs.
Sign-up for UPDATE: Delta, Smith & Wesson jump; Morgan Stanley, J&J disappoint investment picks
2015/1/20
By Anora Mahmudova and Carla Mozee, MarketWatch Morgan Stanley disappoints; Delta and Halliburton top estimates NEW YORK (MarketWatch) -- U.S. stocks moved sharply lower on Tuesday, amid escalating nervousness in global markets, which has seen investors flock to haven assets such as gold and government bonds.
Sign-up for UPDATE: Dow falls triple-digits amid global growth worries investment picks
2015/1/20
By Wallace Witkowski and William Watts, MarketWatch Two months of gold ETF outflows reversed in two days SAN FRANCISCO (MarketWatch) -- Gold traded at its highest price in five months Tuesday with investors rushing into exchange traded funds for the metal after the Swiss National Bank last week triggered turmoil in currency markets and investors looked ahead to this week's meeting of the European Central Bank.
Sign-up for UPDATE: Gold flirts with $1,300 as investors seek havens investment picks
2015/1/20
By Wallace Witkowski and William Watts, MarketWatch Two months of gold ETF outflows reversed in two days SAN FRANCISCO (MarketWatch) -- Gold gained for a seventh straight day to settle at its highest price in five months Tuesday, after the Swiss National Bank last week triggered turmoil in currency markets and investors looked ahead to this week's meeting of the European Central Bank.
Sign-up for UPDATE: Gold settles at highest level in 5 months investment picks
2015/1/20
Shares of IBM (IBM) declined in after-hours trade Tuesday after the company reported a 12% decline in fourth-quarter sales.
Sign-up for UPDATE: IBM sales fall steeper than expected investment picks
2015/1/20
SeviceNow, Inc. NOW Oct.
Sign-up for UPDATE: Major U.S. benchmarks challenge -2- investment picks
2015/1/20
By Michael Ashbaugh, MarketWatch Focus: Biotech, IBB, CELG, NTES, PIR, IRM, FRO CINCINNATI (MarketWatch) -- Despite a volatile 2015 start, the U.S. markets' price action remains technical.
Sign-up for UPDATE: Major U.S. benchmarks challenge last-ditch support investment picks
2015/1/20
By Wallace Witkowski and Victor Reklaitis, MarketWatch IBM shares slip as revenue comes in light SAN FRANCISCO (MarketWatch) -- Netflix Inc. rallied in the extended session Tuesday after the video streaming service topped earnings and subscriber expectations.
Sign-up for UPDATE: Netflix surges after earnings, subscriber growth beats investment picks
2015/1/20
By Anora Mahmudova and Carla Mozee, MarketWatch Netflix soars after beating estimates by wide margin NEW YORK (MarketWatch) -- U.S. stocks ended Tuesday's choppy session with marginal gains, as technology stocks led advances.
Sign-up for UPDATE: Stocks eke out gains in choppy trade investment picks
2015/1/20
By Anora Mahmudova and Carla Mozee, MarketWatch Morgan Stanley disappoints; Delta and Halliburton top estimates NEW YORK (MarketWatch) -- U.S. stocks erased big, early losses Tuesday, turning modestly higher in afternoon activity as worries about deflation gave way to expectations the European Central Bank will deliver more aggressive stimulus when it meets on Thursday.
Sign-up for UPDATE: Stocks erase losses; S&P 500 turns positive investment picks
2015/1/20
By Anora Mahmudova and Carla Mozee, MarketWatch Morgan Stanley disappoints; Delta and Halliburton top estimates NEW YORK (MarketWatch) -- U.S. stocks trimmed losses but remained under pressure Tuesday, weighed down by escalating nervousness over deflationary pressures that have sent investors flocking to haven assets such as gold and government bonds.
Sign-up for UPDATE: Stocks lose ground as global growth worries hold sway investment picks
2015/1/20
By Henry To Expect another bullish year for Indian stocks I recently embarked on a three-week, four-city trip to India to witness the country's transformative economic changes firsthand.
Sign-up for UPDATE: This emerging market has big money-making potential in 2015 investment picks
2015/1/20
By Rachel Bachman People with the noble New Year's resolution to work out or work out more should mark their calendars: That resolve starts to waver in the third week in January, data show.
Sign-up for UPDATE: This is the week New Year's workout resolutions meet their demise investment picks
2015/1/20
By Carla Mozee, MarketWatch Unilever PLC slipped after downbeat demand comments LONDON (MarketWatch) -- U.K. stocks rose Tuesday, with a fourth consecutive session of gains led by mining shares after a better-than-expected economic-growth figure from China.
Sign-up for UPDATE: U.K. stocks log fourth straight gain; Unilever lags investment picks
2015/1/20
By Anora Mahmudova and Carla Mozee, MarketWatch Morgan Stanley disappoints; Delta and Halliburton top estimates NEW YORK (MarketWatch) -- The U.S. stock market erased early gains on Tuesday, as a slide in oil prices hit energy companies.
Sign-up for UPDATE: U.S. stocks head south as oil slides investment picks
2015/1/20
By Anora Mahmudova and Carla Mozee, MarketWatch Morgan Stanley disappoints; Delta and Halliburton top estimates NEW YORK (MarketWatch) -- U.S. stock futures climbed on Tuesday, in part driven by hopes that European Central Bank will announce its bond-buying program this week.
Sign-up for UPDATE: U.S. stocks: Futures higher amid flurry of results investment picks
2015/1/20
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- U.S. stock futures indicated a higher opening Tuesday, driven, in part, by hopes for central-bank stimulus as a continued pageant of quarterly results roll out.
Sign-up for UPDATE: U.S. stocks: Futures hold to gains after Morgan Stanley results fall short investment picks
2015/1/20
By MarketWatch Cree shares rally on quarterly earnings beat Cree Inc.(CREE)shares rose in the extended session Tuesday after the light-emitting diode maker topped Wall Street expectations for the quarter.
Sign-up for UPDATE: Updates, advisories and surprises investment picks
2015/1/20
By Barbara Kollmeyer, MarketWatch Critical information ahead of the U.S. stock market's open What have we learned over the past few days?
Sign-up for UPDATE: What happens if the ECB pulls a Swiss-style surprise investment picks
2015/1/20
By MarketWatch Johnson & Johnson beats profit expectations, but sales fall shy Shares of Johnson & Johnson(JNJ)slipped 0.1% in premarket trade Tuesday, after the drug giant reported fourth-quarter earnings that beat expectations, but revenue that fell below forecasts.
Sign-up for Updates, advisories and surprises investment picks
2015/1/20
USA TODAY and Gannett Co., Inc. (NYSE: GCI), official US representative to the Cannes Lions International Festival of Creativity, today announced the kickoff of the 2015 US Young Lions competitions.
Sign-up for USA TODAY and Gannett Kick-off the 2015 US Young Lions Competitions, Adding New PR Competition to the Launch investment picks
2015/1/20
Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced that it intends to offer and sell $40 million of its common stock in an underwritten public offering.
Sign-up for Verastem Announces Proposed Public Offering of Common Stock investment picks
2015/1/20
Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced dosing of the first patient in a new clinical trial evaluating the combination of VS-5584, its dual mTORC1/2 and PI3K inhibitor, in combination with VS-6063, the Company’s lead focal adhesion kinase (FAK) inhibitor, in patients with relapsed mesothelioma.
Sign-up for Verastem Doses First Patient in Phase 1 Clinical Trial Evaluating VS-5584 in Combination with VS-6063 in Mesothelioma investment picks
2015/1/20
Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced that VS-5584 has received orphan medicinal product designation from the European Commission for use in mesothelioma.
Sign-up for Verastem Receives Orphan Medicinal Product Designation from the European Commission for VS-5584 in Mesothelioma investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: UPDATE: 3 health resolutions you can actually keep in 2015 to Verastem Receives Orphan Medicinal Product Designation from the European Commission for VS-5584 in Mesothelioma
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent